-
European Commission head Ursula von der Leyen said on Friday the EU was in discussions with more companies to secure potential COVID-19 vaccines, as reported in London South East.
-
She indicated that "the commission has already concluded two advance purchase agreements and it is negotiating five more, and we are in discussions with four more companies."
-
The EU has so far announced supply deals for the potential vaccines being developed by AstraZeneca and by a partnership between Sanofi and GlaxoSmithKline.
-
It has also said publicly that it was in advanced negotiations to secure vaccines being developed by Moderna, Johnson & Johnson, CureVac and a partnership between Pfizer and BioNTech.
-
Meanwhile, a senior EU source recently said the bloc is also in talks with Novavax for a seventh vaccine.
To read more NewsPoints articles, click here.
